시지메드텍
4,950KRWMarket close of 10/21 (Wed)
Up +1.02%+50KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)4,680KRWDown -5.45%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 4,900
- High
- 5,080
- Low
- 4,800
- Day range
- Day range low 4,800 high 5,080, open 4,900, close 4,950, previous close 4,900
- Volume
- 6×10K shares
- 305.39 million KRW 0.69× the 20-session average
Market close of 10/21 (Wed)
Usual range
Nothing unusual in the 2 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily movenot verifiedOnly 10 daily bars to compare, so not verified
- Trading valuenot verifiedNot enough 20-session trading value data, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 3
- Foreign & institutionalnot verified
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue13.0B KRW
- vs. year ago
- +10.9%
- vs. prior quarter
- +13.3%
- Operating income238.89 million KRW
- vs. year ago
- -59.8%
- vs. prior quarter
- -26.7%
- Operating margin1.8%
- vs. year ago
- -3.2 pp
- vs. prior quarter
- -1.0 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.